DIESE MELDUNG PER E-MAIL VERSENDEN
Positive Results from Phase III Study Evaluating Oral OTEZLA® (Apremilast) or Injectable Etanercept versus Placebo in Patients with Moderate to Severe Plaque Psoriasis Presented at AAD
*
marks required fields
Name des Empfängers:
*
E-Mail des Empfängers:
Nachricht:
*
Enter security words: